These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 24696731)
1. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma. Li J; Sheng C; Li W; Zheng JH Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731 [TBL] [Abstract][Full Text] [Related]
2. Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder. Yang FQ; Huang JH; Liu M; Yang FP; Li W; Wang GC; Che JP; Zheng JH Int J Clin Exp Pathol; 2014; 7(1):340-7. PubMed ID: 24427355 [TBL] [Abstract][Full Text] [Related]
3. Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder. Yan Y; Yang FQ; Zhang HM; Li J; Li W; Wang GC; Che JP; Zheng JH; Liu M Int J Clin Exp Pathol; 2014; 7(7):4231-8. PubMed ID: 25120803 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma. Li W; Liu M; Feng Y; Xu YF; Che JP; Wang GC; Zheng JH; Gao HJ Int J Clin Exp Pathol; 2013; 6(6):1086-94. PubMed ID: 23696926 [TBL] [Abstract][Full Text] [Related]
5. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer. Yang FQ; Yang FP; Li W; Liu M; Wang GC; Che JP; Huang JH; Zheng JH Int J Clin Exp Pathol; 2014; 7(1):110-22. PubMed ID: 24427331 [TBL] [Abstract][Full Text] [Related]
6. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. Parker AS; Eckel-Passow JE; Serie D; Hilton T; Parasramka M; Joseph RW; Wu KJ; Cheville JC; Leibovich BC Eur Urol; 2014 Nov; 66(5):929-35. PubMed ID: 24388441 [TBL] [Abstract][Full Text] [Related]
7. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma. Laba P; Wang J; Zhang J BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival. Zhao JJ; Chen PJ; Duan RQ; Li KJ; Wang YZ; Li Y Int J Clin Exp Pathol; 2014; 7(6):3318-23. PubMed ID: 25031755 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-497 is associated with poor prognosis in renal cancer. Zhao X; Zhao Z; Xu W; Hou J; Du X Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma. Yuan Y; Yang X; Li Y; Liu Q; Wu F; Qu H; Gao H; Ge J; Xu Y; Wang H; Wang Y; Zhao Z Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752 [TBL] [Abstract][Full Text] [Related]
11. Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma. Peters I; Dubrowinskaja N; Tezval H; Kramer MW; von Klot CA; Hennenlotter J; Stenzl A; Scherer R; Kuczyk MA; Serth J Target Oncol; 2015 Jun; 10(2):267-75. PubMed ID: 25230694 [TBL] [Abstract][Full Text] [Related]
12. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas. Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695 [TBL] [Abstract][Full Text] [Related]
13. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma. Qi C; Ma H; Zhang HT; Gao JD; Xu Y Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808 [TBL] [Abstract][Full Text] [Related]
14. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival. Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma. Xue YJ; Xiao RH; Long DZ; Zou XF; Wang XN; Zhang GX; Yuan YH; Wu GQ; Yang J; Wu YT; Xu H; Liu FL; Liu M J Transl Med; 2012 Sep; 10():200. PubMed ID: 23006512 [TBL] [Abstract][Full Text] [Related]
16. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma. Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105 [TBL] [Abstract][Full Text] [Related]
17. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival. Du P; Ye L; Yang Y; Jiang WG Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253 [TBL] [Abstract][Full Text] [Related]
18. Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma. Wang J; Li T; Li X; Zhang Y; Wang X BMC Urol; 2021 Aug; 21(1):108. PubMed ID: 34391411 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of phosphoprotein phosphatase 2A predicts worse prognosis in patients with breast cancer: a 15-year follow-up. Chen PM; Chu PY; Tung SL; Liu CY; Tsai YF; Lin YS; Wang WL; Wang YL; Lien PJ; Chao TC; Tseng LM Hum Pathol; 2017 Aug; 66():93-100. PubMed ID: 28603063 [TBL] [Abstract][Full Text] [Related]
20. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma. Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]